Study Highlights Semen Testing and Reproductive Success Amid COVID-19 for HIV-Infected Men
TL;DR
HIV-infected men pursued semen testing for fertility procedures, resulting in 32 reported pregnancies and 43 babies born.
BFR conducts stem cell and related research including patient-specific stem cells, circadian rhythm impact on embryo development, and prostate cancer screening.
The research contributes to curing HIV disease, spinal cord injury, and creating accurate tests for prostate cancer, ultimately improving lives.
The research findings include breakthroughs in stem cell therapies, embryo development, and educational events for sharing research information.
Found this article helpful?
Share it with your network and spread the knowledge!
A recent study has outlined the outcomes of assisted reproductive technology (ART) testing for HIV-infected men during the COVID-19 lockdown period from April 2020 to March 2022. Conducted by the BRF biomedical institute, the study involved semen testing for fertility procedures across 12 countries, resulting in no reported infections from embryo transfers, and leading to 32 pregnancies and 43 births.
During the two-year period, 156 HIV-infected men pursued semen testing, and 82 gestational carriers and wives underwent embryo transfers without contracting the virus. These procedures took place in nine fertility clinics, culminating in the birth of 43 babies to both gestational carriers and wives, demonstrating the effectiveness and safety of the fertility procedures even amid the pandemic.
The BRF institute, known for its stem cell research and innovative approaches to treating diseases considered incurable, employs various strategies to advance biomedical research. These include creating patient-specific stem cells for treating HIV and spinal cord injuries, examining the impact of circadian rhythms on embryo development, and developing accurate prostate cancer screening tests.
Additionally, BRF organizes educational events such as the Activated Egg Symposium and the Spinal Cord Workshop to facilitate information sharing among researchers and clinicians. The institute also offers laboratory products and services, including the SPAR (Special Program of Assisted Reproduction) for safe procreation, mail-in test kits for infertility and other conditions, and specialized culture mediums like GEM (Gamete-Embryo Medium).
BRF's efforts are further supported by educational media, including newsletters, videos of groundbreaking talks, and tutorials on stem cell research. Despite facing funding challenges due to federal moratoriums on certain types of research, the institute continues to make significant strides in biomedical advancements, as evidenced by the successful reproductive outcomes during the COVID-19 era.
For more detailed information, the full article can be accessed here.
Curated from 24-7 Press Release
